Diagnostic Company LumiraDX Goes Public In $5Bn SPAC Merger
Executive Summary
LumiraDX secured $400m in new debt financing and will use all proceeds to fund growth.
You may also be interested in...
CM Life Sciences II To Combine With Proteomics SomaLogic In Latest SPAC Deal
The SPAC deal between CM Life Sciences II and SomaLogic is valued at $1.25bn.
Blank Check Companies’ Hunt For Innovative Medtech Start-Ups To Heat Up Further, Experts Predict
As the SPAC boom continues, innovative medtechs are expected to become acquisition targets.
Behavioral Health Company Two Chairs Secures $72M In Equity And Debt Infusion
Two Chairs, which uses algorithms to match the right therapists with patients, secured $72m in investment to expand its business.